IS6999A
(en )
2003-10-24
Antibodies that block the Cripto protein and their use
DK1417175T3
(en )
2013-10-28
SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
DE60212600D1
(en )
2006-08-03
AUDIOCODING AND DECODING
DE50112013D1
(en )
2007-03-22
DEODORANTIA AND ANTIPERSPIRANTIES
DK1746375T3
(en )
2013-02-11
Oxygen-fueled combustion system and uses thereof
EP1423120A4
(en )
2005-12-28
2h-phthalazin-1-ones and methods for use thereof
IS6779A
(en )
2003-04-11
Human antibody against LT-beta-R
NO20034159D0
(en )
2003-09-18
The estrogen-gestagen combination preparation and its use
NO20033418L
(en )
2003-09-30
Immune regulatory antibodies and their use
NO20041975D0
(en )
2004-05-13
Bicyclic oxopyridine and oxopyrimidine derivatives
ITRM20020264A0
(en )
2002-05-15
ABSORBENT ARTICLE AND PROCEDURE FOR ITS MANUFACTURE.
FI20010694A0
(en )
2001-04-03
The implant
EP1375518A4
(en )
2004-12-08
Anti-osteopontin antibody and use thereof
HK1061212A1
(en )
2004-09-10
Pyranoindazoles and their use for the treatment ofglaucoma
DE60220486D1
(en )
2007-07-19
Switch-back device and switch-back method
DE60144265D1
(en )
2011-05-05
SEMICONDUCTOR COMPONENT AND ITS MANUFACTURE
EP1589033A4
(en )
2006-04-12
Antibody and use thereof
AU2002357934A8
(en )
2003-07-24
Humanized lactoferrin and uses thereof
DE60205008D1
(en )
2005-08-18
Kettelverfahren and device
IS8914A
(en )
2010-07-21
Antibodies that block the Cripto protein and their use
DE60219418T8
(en )
2008-04-30
SILANOLLPHENOL AND NAPHTHOLE
DE50203221D1
(en )
2005-06-30
SIGNALING METHOD AND ARRANGEMENT
EP1367123A4
(en )
2005-10-12
Neurotonin and use thereof
EP1437367A4
(en )
2005-01-26
Antibody and use thereof
EP1627888A4
(en )
2007-04-18
Antibody and use thereof